Domoprednate
| Clinical data | |
|---|---|
| Trade names | Stermonid |
| Other names | Ro 12-7024; 11β-Hydroxy-D-homopregna-1,4-diene-3,20-dione 17α-butyrate |
| Routes of administration | Topical |
| Drug class | Corticosteroid; Glucocorticoid |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.060.441 |
| Chemical and physical data | |
| Formula | C26H36O5 |
| Molar mass | 428.569 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Domoprednate (brand name Stermonid; developmental code name Ro 12-7024) is a synthetic glucocorticoid corticosteroid which was developed in the late 1970s and 1980s.